Hesham Ibrahim El-Askary
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hesham Ibrahim El-Askary has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Meselhy Ragab Meselhy
Department of Pharmacognosy, Faculty of Pharmacy, Cairo University, Cairo, Egypt
3 shared publications - Ghada Ahmed Fawzy
Pharmacognosy Department, Faculty of Pharmacy, Cairo University, Kasr el Aini st., Cairo 11562, Egypt
2 shared publications - Jin Zhang
State Key Laboratory of Subtropical Silviculture, College of Forestry and Biotechnology, Zhejiang A&F University, Hangzhou, Zhejiang 311300, China
2 shared publications - Mei Wang
Natural Products Utilization Research Unit, Agricultural Research Service, United States Department of Agriculture, University, MS 38677, USA
2 shared publications - Mohamed Ali Ibrahim
National Center for Natural Products Research, School of Pharmacy, University of Mississippi, University, MS 38677, USA
2 shared publications - Mona Hafez Hetta
Department of Pharmacognosy, Faculty of Pharmacy, Fayoum University, Fayoum 63514, Egypt
2 shared publications
Latest Publications
- Open Access
- 19 February 2025
- Published by Wroclaw Medical University in Dental and Medical Problems
- Vol. 62 (1) , 79-87
Potential protective role of parsley on induced tongue carcinogenesis in albino rats
Parsley has been traditionally used as a food additive and herbal medicament. The flavonoid apigenin and its glycosides constitute the most abundant phenolic compounds found in parsley. They exhibit numerous pharmacological effects, including antioxidant, anti-inflammatory, antitoxic, and anticancer properties. The aim of the study was to evaluate the potential chemopreventive effect of orally administered parsley extract on tongue cancer induced by 7,12-dimethylbenz[a]anthracene (DMBA) and formaldehyde in rats. A total of 36 adult male albino rats were randomly allocated into 3 equal groups: the parsley group was administered 2 g/kg body weight parsley extract through oral gavage 3 times per week; the carcinogenesis group received a topical application of 0.5% DMBA in acetone and formaldehyde to the tongues; and the parsley-treated carcinogenesis group was administered parsley extract combined with a topical application of DMBA and formaldehyde. Additionally, a group of 5 rats served as a negative control group. After 8 weeks, the tongues of the rats were dissected and subjected to histopathological, immunohistochemical, histomorphometric, and quantitative real-time polymerase chain reaction (qRT-PCR) analyses. Histopathologically, the tongues from the carcinogenesis group revealed several signs of hyperplasia, dysplasia and the invasion of dysplastic cells into the underlying connective tissue. The tongues of the parsley-treated carcinogenesis group exhibited a reduction in dysplastic changes and almost regained their normal architecture, as observed in both the control and parsley groups. The immunohistochemical analysis of the area percentage of caspase-3 immunoexpression revealed a significant increase in the parsley-treated carcinogenesis group compared to the carcinogenesis group, which approached the results observed in both the control and parsley groups. The qRT-PCR results of tumor necrosis factor-alpha (TNF-α) expression displayed a significantly decreased expression in the parsley-treated carcinogenesis group as compared to the carcinogenesis group. These findings were comparable to those observed in the control and parsley groups. In a rat model, oral administration of parsley extract has been shown to impede the initiation of several cellular carcinogenic changes in tongue tissues.
- 19 February 2025
- Published by Wroclaw Medical University in Dental and Medical Problems
- Vol. 62 (1) , 79-87
Open AccessPotential protective role of parsley on induced tongue carcinogenesis in albino rats
Parsley has been traditionally used as a food additive and herbal medicament. The flavonoid apigenin and its glycosides constitute the most abundant phenolic compounds found in parsley. They exhibit numerous pharmacological effects, including antioxidant, anti-inflammatory, antitoxic, and anticancer properties. The aim of the study was to evaluate the potential chemopreventive effect of orally administered parsley extract on tongue cancer induced by 7,12-dimethylbenz[a]anthracene (DMBA) and formaldehyde in rats. A total of 36 adult male albino rats were randomly allocated into 3 equal groups: the parsley group was administered 2 g/kg body weight parsley extract through oral gavage 3 times per week; the carcinogenesis group received a topical application of 0.5% DMBA in acetone and formaldehyde to the tongues; and the parsley-treated carcinogenesis group was administered parsley extract combined with a topical application of DMBA and formaldehyde. Additionally, a group of 5 rats served as a negative control group. After 8 weeks, the tongues of the rats were dissected and subjected to histopathological, immunohistochemical, histomorphometric, and quantitative real-time polymerase chain reaction (qRT-PCR) analyses. Histopathologically, the tongues from the carcinogenesis group revealed several signs of hyperplasia, dysplasia and the invasion of dysplastic cells into the underlying connective tissue. The tongues of the parsley-treated carcinogenesis group exhibited a reduction in dysplastic changes and almost regained their normal architecture, as observed in both the control and parsley groups. The immunohistochemical analysis of the area percentage of caspase-3 immunoexpression revealed a significant increase in the parsley-treated carcinogenesis group compared to the carcinogenesis group, which approached the results observed in both the control and parsley groups. The qRT-PCR results of tumor necrosis factor-alpha (TNF-α) expression displayed a significantly decreased expression in the parsley-treated carcinogenesis group as compared to the carcinogenesis group. These findings were comparable to those observed in the control and parsley groups. In a rat model, oral administration of parsley extract has been shown to impede the initiation of several cellular carcinogenic changes in tongue tissues.
- Open Access
- 31 October 2023
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 13 (46) , 32296-32320
Design, synthesis, and biological evaluation of new pyrimidine-5-carbonitrile derivatives as novel anti-cancer, dual EGFR WT /COX-2 inhibitors with docking studies
A series of pyrimidine-5-carbonitriles was designed and synthesized as potential anti-cancer agents with dual EGFR WT /COX-2 inhibition. Compounds 4e and 4f disclosed the highest activity on all NCI60 cell lines.
- 31 October 2023
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 13 (46) , 32296-32320
Open AccessDesign, synthesis, and biological evaluation of new pyrimidine-5-carbonitrile derivatives as novel anti-cancer, dual EGFR WT /COX-2 inhibitors with docking studies
A series of pyrimidine-5-carbonitriles was designed and synthesized as potential anti-cancer agents with dual EGFR WT /COX-2 inhibition. Compounds 4e and 4f disclosed the highest activity on all NCI60 cell lines.
- Open Access
- 22 September 2022
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 32 (5) , 774-785
Phytochemical Investigation of Egyptian Spinach Leaves, a Potential Source for Antileukemic Metabolites: In Vitro and In Silico Study
Spinacia oleracea L., Amaranthaceae, leaves cultivated in Egypt demonstrated a potential antileukemic activity against the chronic myeloid leukemia, K562 cell line. Thus, the aim of this study is to carry out a phytochemical investigation of S. oleracea leaves as well as the isolation of its antileukemic phytoconstituents. Phytochemical investigation of S. oleracea leaves resulted in the isolation of seventeen known compounds. The biological study revealed that compounds hexaprenol, phytol, and 18-[(1-oxohexadecyl) oxy]-9-octadecenoic acid exhibited a remarkable antiproliferative activity against K562 cells in vitro. A mechanistic in silico study showed that hexaprenol, phytol, and 18-[(1-oxohexadecyl) oxy]-9-octadecenoic acid exhibited a strong binding affinity towards topoisomerase (docking score −12.50, −9.19, and −13.29 kcal/mol, respectively), and showed as well a strong binding affinity towards Abl kinase (docking score −11.91, −9.35, and −12.59 kcal/mol, respectively). Molecular dynamics study revealed that 18-[(1-oxohexadecyl) oxy]-9-octadecenoic acid produced stable complexes with both topoisomerase and Abl kinase with RMSD values of 1.81 and 1.85 Å, respectively. As a result of our findings, we recommend more in vivo and preclinical studies to confirm the potential benefit of spinach leaves for chronic myeloid leukemia patients. Graphical Abstract
- 22 September 2022
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 32 (5) , 774-785
Open AccessPhytochemical Investigation of Egyptian Spinach Leaves, a Potential Source for Antileukemic Metabolites: In Vitro and In Silico Study
Spinacia oleracea L., Amaranthaceae, leaves cultivated in Egypt demonstrated a potential antileukemic activity against the chronic myeloid leukemia, K562 cell line. Thus, the aim of this study is to carry out a phytochemical investigation of S. oleracea leaves as well as the isolation of its antileukemic phytoconstituents. Phytochemical investigation of S. oleracea leaves resulted in the isolation of seventeen known compounds. The biological study revealed that compounds hexaprenol, phytol, and 18-[(1-oxohexadecyl) oxy]-9-octadecenoic acid exhibited a remarkable antiproliferative activity against K562 cells in vitro. A mechanistic in silico study showed that hexaprenol, phytol, and 18-[(1-oxohexadecyl) oxy]-9-octadecenoic acid exhibited a strong binding affinity towards topoisomerase (docking score −12.50, −9.19, and −13.29 kcal/mol, respectively), and showed as well a strong binding affinity towards Abl kinase (docking score −11.91, −9.35, and −12.59 kcal/mol, respectively). Molecular dynamics study revealed that 18-[(1-oxohexadecyl) oxy]-9-octadecenoic acid produced stable complexes with both topoisomerase and Abl kinase with RMSD values of 1.81 and 1.85 Å, respectively. As a result of our findings, we recommend more in vivo and preclinical studies to confirm the potential benefit of spinach leaves for chronic myeloid leukemia patients. Graphical Abstract
- Open Access
- 29 August 2022
- Published by Wiley in Journal of Chemistry
- Vol. 2022, 1-14
Phytochemical Investigation of Egyptian Riverhemp: A Potential Source of Antileukemic Metabolites
As part of our research groups continuous efforts to find alternative treatments for cancer, the aqueous ethanol extract of Sesbania sesban L. Merr. (SS, Egyptian riverhemp) demonstrated an antileukemic activity against K562 cell line. Bioguided fractionation of SS leaves hydroethanolic extract resulted in the isolation of one new compound (33) named as hederatriol 3-O-β-D-glucuronic acid methyl ester as well as 34 known compounds. Seven compounds ((34), (22), (20), (24), (21), (19), and (35)) showed high antiproliferative effects (IC50=22.3, 30.8, 31.3, 33.7, 36.6, 37.5, and 41.5μM, respectively), while four compounds ((32), (5), (29), and (1)) showed milder activities (IC50=56.4, 67.6, 83.3, and 112.3μM, respectively). A mechanistic study was further carried out on a molecular genetics level against several transcription factors signaling pathways that are incorporated in the incidence of cancer. The results showed that compounds (22) and (21) demonstrated a specific inhibition of Wnt pathway (IC50=3.8 and 4.6μM, respectively), while compound (22) showed a specific inhibition of Smad pathway (IC50=3.8μM). Compound (34) strongly altered the signaling of Smad and E2F pathways (IC50=5μM). The bioactive metabolites were further investigated in silico by docking against several targets related to K562cell line. The results showed that compounds (22) and (34) exhibited a strong binding affinity towards topoisomerase (docking score=7.81 and 9.30Kcal/Mole, respectively). Compounds (22) and (34) demonstrated a strong binding affinity towards EGFR-tyrosine kinase (docking score=7.12 and 7.35Kcal/Mole, respectively). Moreover, compound (34) showed a strong binding affinity towards Abl kinase (docking score=7.05Kcal/Mole).
- 29 August 2022
- Published by Wiley in Journal of Chemistry
- Vol. 2022, 1-14
Open AccessPhytochemical Investigation of Egyptian Riverhemp: A Potential Source of Antileukemic Metabolites
As part of our research groups continuous efforts to find alternative treatments for cancer, the aqueous ethanol extract of Sesbania sesban L. Merr. (SS, Egyptian riverhemp) demonstrated an antileukemic activity against K562 cell line. Bioguided fractionation of SS leaves hydroethanolic extract resulted in the isolation of one new compound (33) named as hederatriol 3-O-β-D-glucuronic acid methyl ester as well as 34 known compounds. Seven compounds ((34), (22), (20), (24), (21), (19), and (35)) showed high antiproliferative effects (IC50=22.3, 30.8, 31.3, 33.7, 36.6, 37.5, and 41.5μM, respectively), while four compounds ((32), (5), (29), and (1)) showed milder activities (IC50=56.4, 67.6, 83.3, and 112.3μM, respectively). A mechanistic study was further carried out on a molecular genetics level against several transcription factors signaling pathways that are incorporated in the incidence of cancer. The results showed that compounds (22) and (21) demonstrated a specific inhibition of Wnt pathway (IC50=3.8 and 4.6μM, respectively), while compound (22) showed a specific inhibition of Smad pathway (IC50=3.8μM). Compound (34) strongly altered the signaling of Smad and E2F pathways (IC50=5μM). The bioactive metabolites were further investigated in silico by docking against several targets related to K562cell line. The results showed that compounds (22) and (34) exhibited a strong binding affinity towards topoisomerase (docking score=7.81 and 9.30Kcal/Mole, respectively). Compounds (22) and (34) demonstrated a strong binding affinity towards EGFR-tyrosine kinase (docking score=7.12 and 7.35Kcal/Mole, respectively). Moreover, compound (34) showed a strong binding affinity towards Abl kinase (docking score=7.05Kcal/Mole).
- Open Access
- 29 December 2021
- Published by Taylor & Francis in Drug Delivery
- Vol. 29 (1) , 62-74
The efficacy of Origanum majorana nanocubosomal systems in ameliorating submandibular salivary gland alterations in streptozotocin-induced diabetic rats
Diabetes mellitus is a challenging health problem. Salivary gland dysfunction is one of its complications. Current treatments possess numerous adverse effects. Therefore, herbal extracts have emerged as a promising approach for safe and effective treatment. However, they are required in large doses to achieve the desired effect. Accordingly, Origanum majorana extract (OE) was incorporated into nano-sized systems to enhance its biological effects at lower dosages. OE was standardized against rosmarinic acid (RA) and then loaded into nano-cubosomal (NC) systems via a 23 full-factorial design. Two optimum nano-systems at different drug loads (2.08 or 1.04 mg-RA/mL) were selected and assessed in vivo to compare their effects in streptozotocin-induced diabetic rats against conventional OE (2.08 mg-RA/mL). Blood glucose was evaluated weekly. Submandibular salivary glands were processed for histopathological examination and nuclear factor-erythroid 2-related factor 2 (Nrf2), Kelch-like ECH-associated protein 1 (Keap1), and p38-MAPK gene expression analysis. NC systems were successfully prepared and optimized where the optimum systems showed nano-sized vesicles (210.4–368.3 nm) and high zeta potential values. In vivo results showed a significant lower blood glucose in all treated groups, with an exceptional reduction with NC formulations. Marked histopathological improvement was observed in all OE-treated groups, with OE-NC4 (2.08 mg-RA/mL) demonstrating the best features. This was supported by RT-PCR; where the OE-NC4 group recorded the highest mean value of Nrf2 and the least mean values of Keap1 and p38-MAPK, followed by OE-NC3 and OE groups. In conclusion, OE-loaded NC enhanced the anti-hyperglycemic effect of OE and ameliorated diabetic gland alterations compared to conventional OE. Thus, cubosomal nano-systems could be anticipated as potential carriers for the best outcome with OE.
- 29 December 2021
- Published by Taylor & Francis in Drug Delivery
- Vol. 29 (1) , 62-74
Open AccessThe efficacy of Origanum majorana nanocubosomal systems in ameliorating submandibular salivary gland alterations in streptozotocin-induced diabetic rats
Diabetes mellitus is a challenging health problem. Salivary gland dysfunction is one of its complications. Current treatments possess numerous adverse effects. Therefore, herbal extracts have emerged as a promising approach for safe and effective treatment. However, they are required in large doses to achieve the desired effect. Accordingly, Origanum majorana extract (OE) was incorporated into nano-sized systems to enhance its biological effects at lower dosages. OE was standardized against rosmarinic acid (RA) and then loaded into nano-cubosomal (NC) systems via a 23 full-factorial design. Two optimum nano-systems at different drug loads (2.08 or 1.04 mg-RA/mL) were selected and assessed in vivo to compare their effects in streptozotocin-induced diabetic rats against conventional OE (2.08 mg-RA/mL). Blood glucose was evaluated weekly. Submandibular salivary glands were processed for histopathological examination and nuclear factor-erythroid 2-related factor 2 (Nrf2), Kelch-like ECH-associated protein 1 (Keap1), and p38-MAPK gene expression analysis. NC systems were successfully prepared and optimized where the optimum systems showed nano-sized vesicles (210.4–368.3 nm) and high zeta potential values. In vivo results showed a significant lower blood glucose in all treated groups, with an exceptional reduction with NC formulations. Marked histopathological improvement was observed in all OE-treated groups, with OE-NC4 (2.08 mg-RA/mL) demonstrating the best features. This was supported by RT-PCR; where the OE-NC4 group recorded the highest mean value of Nrf2 and the least mean values of Keap1 and p38-MAPK, followed by OE-NC3 and OE groups. In conclusion, OE-loaded NC enhanced the anti-hyperglycemic effect of OE and ameliorated diabetic gland alterations compared to conventional OE. Thus, cubosomal nano-systems could be anticipated as potential carriers for the best outcome with OE.
- 13 September 2019
- Published by ACG Publications in Records of Natural Products
- Vol. 14 (1) , 1-17
Roselle Seed Oil and its Nano-Formulation Alleviated Oxidative Stress, Activated Nrf2 and Downregulated m-RNA Expression Genes of Pro-inflammatory Cytokines in Paracetamol-intoxicated Rat Model
Roselle (Hibiscus sabdariffa L.) seeds, traditionally used in liver disorders, have recently attracted more attention as a new source of healthy edible oil with anti-inflammatory and antioxidant activities. However, its hepatoprotective effect has not been explored yet. In the current study, the hepatoprotective potential of roselle seed oil (RSO; 0.6, 4 and 8 ml/kg) and its nano-formulation (RSO-NE; 4 and 8 ml/kg), and their possible underlying mechanism were investigated in a paracetamol-induced hepatotoxicity rat model, compared to silymarin. RSO and RSO-NE protected the liver against paracetamol-intoxication and maintained the overall architecture of liver tissues in a dose dependent manner. Additionally, hepatic nuclear factor-erythroid 2-related factor2 (Nrf2) and glutathione (GSH) increased significantly in pre-treated groups, while malondialdehyde (MDA) decreased. Moreover, RSO and RSO-NE significantly inhibited paracetamol-induced mRNA expression of pro-inflammatory cytokines (TNF-α and IL-6). Chemical analysis of RSO showed fatty acids (mainly linoleic, oleic, palmitic and stearic acids), n-eicosane, β-sitosterol and tocopherols as the major constituents, which contributed synergistically to its protective effect. The efficacy of RSO-NE (8 ml/Kg) was superior to its corresponding unformulated oil (0.6 ml/kg), indicating its enhanced bioavailability. These findings encourage the use of RSO in development of health promoting products such as food supplements, functional food and nutraceuticals for the prevention of liver disease.
- 13 September 2019
- Published by ACG Publications in Records of Natural Products
- Vol. 14 (1) , 1-17
Roselle Seed Oil and its Nano-Formulation Alleviated Oxidative Stress, Activated Nrf2 and Downregulated m-RNA Expression Genes of Pro-inflammatory Cytokines in Paracetamol-intoxicated Rat Model
Roselle (Hibiscus sabdariffa L.) seeds, traditionally used in liver disorders, have recently attracted more attention as a new source of healthy edible oil with anti-inflammatory and antioxidant activities. However, its hepatoprotective effect has not been explored yet. In the current study, the hepatoprotective potential of roselle seed oil (RSO; 0.6, 4 and 8 ml/kg) and its nano-formulation (RSO-NE; 4 and 8 ml/kg), and their possible underlying mechanism were investigated in a paracetamol-induced hepatotoxicity rat model, compared to silymarin. RSO and RSO-NE protected the liver against paracetamol-intoxication and maintained the overall architecture of liver tissues in a dose dependent manner. Additionally, hepatic nuclear factor-erythroid 2-related factor2 (Nrf2) and glutathione (GSH) increased significantly in pre-treated groups, while malondialdehyde (MDA) decreased. Moreover, RSO and RSO-NE significantly inhibited paracetamol-induced mRNA expression of pro-inflammatory cytokines (TNF-α and IL-6). Chemical analysis of RSO showed fatty acids (mainly linoleic, oleic, palmitic and stearic acids), n-eicosane, β-sitosterol and tocopherols as the major constituents, which contributed synergistically to its protective effect. The efficacy of RSO-NE (8 ml/Kg) was superior to its corresponding unformulated oil (0.6 ml/kg), indicating its enhanced bioavailability. These findings encourage the use of RSO in development of health promoting products such as food supplements, functional food and nutraceuticals for the prevention of liver disease.
- Open Access
- 1 March 2019
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 29 (2) , 213-220
Characterization of hepatoprotective metabolites from Artemisia annua and Cleome droserifolia using HPLC/PDA/ESI/MS–MS
- 1 March 2019
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 29 (2) , 213-220
Open AccessCharacterization of hepatoprotective metabolites from Artemisia annua and Cleome droserifolia using HPLC/PDA/ESI/MS–MS
- 1 August 2015
- Published by Elsevier in Phytomedicine
- Vol. 22 (9) , 829-836
Aldose reductase inhibition of a saponin-rich fraction and new furostanol saponin derivatives from Balanites aegyptiaca
- 1 August 2015
- Published by Elsevier in Phytomedicine
- Vol. 22 (9) , 829-836
Aldose reductase inhibition of a saponin-rich fraction and new furostanol saponin derivatives from Balanites aegyptiaca
- Open Access
Terpenoids from Cleome droserifolia (Forssk.) Del
A new diacetyl triterpene lactone, drosericarpone (2), was isolated from the hexane extract of the herb Cleome droserifolia, together with buchariol (1, a sesquiterpene oxide, isolated for the first time from Cleome species) and stigmasterol glucoside (3). The structures of 1-3 were identified by spectroscopic means.
Open AccessTerpenoids from Cleome droserifolia (Forssk.) Del
A new diacetyl triterpene lactone, drosericarpone (2), was isolated from the hexane extract of the herb Cleome droserifolia, together with buchariol (1, a sesquiterpene oxide, isolated for the first time from Cleome species) and stigmasterol glucoside (3). The structures of 1-3 were identified by spectroscopic means.
- Open Access
Sesquiterpenes from Cymbopogon proximus
In addition to four previously reported compounds: proximadiol (1), 5α-hydroxy-β-eudesmol (2), 1β-hydroxy-β-eudesmol (4) and 1β-hydroxy-α-eudesmol (5), two new sesquiterpenes, 5α-hydroperoxy-β-eudesmol (3) and 7α,11-dihydroxycadin-10(14)-ene (6) were isolated from the unsaponifiable fraction of the petroleum ether extract of Cymbopogon proximus STAPF. Isolation of compounds 2, 4 and 5 from the genus Cymbopogon is reported for the first time. The structure elucidation of these compounds was based primarily on 1D and 2D-NMR analyses.
Open AccessSesquiterpenes from Cymbopogon proximus
In addition to four previously reported compounds: proximadiol (1), 5α-hydroxy-β-eudesmol (2), 1β-hydroxy-β-eudesmol (4) and 1β-hydroxy-α-eudesmol (5), two new sesquiterpenes, 5α-hydroperoxy-β-eudesmol (3) and 7α,11-dihydroxycadin-10(14)-ene (6) were isolated from the unsaponifiable fraction of the petroleum ether extract of Cymbopogon proximus STAPF. Isolation of compounds 2, 4 and 5 from the genus Cymbopogon is reported for the first time. The structure elucidation of these compounds was based primarily on 1D and 2D-NMR analyses.